Mark Shapiro
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 16
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 15
- Microbiology top 5%
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 4
- CAR-T cell therapy research 4
-
- Lung Cancer Diagnosis and Treatment 7
- Lung Cancer Treatments and Mutations 7
-
- Eosinophilic Disorders and Syndromes 6
-
- Acute Lymphoblastic Leukemia research 6
- Co-authors
- Juan P. WisniveskyCynthia ChinTodd S. WeiserSteven SwansonJörge E. CortesCameron D. WrightRobert J. KorstShubin Sheng
- Cited by
- HematologyGeneticsMicrobiology
- Journals
- Blood (9 papers)Journal of Clinical Oncology (6 papers)The Annals of Thoracic Surgery (3 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Mark Shapiro
46 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 91
- Hematology 351
- Genetics 317
- Microbiology 21
- Oncology 471
- Pulmonary and Respiratory Medicine 537
Countries citing papers authored by Mark Shapiro
This map shows the geographic impact of Mark Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shapiro more than expected).
Fields of papers citing papers by Mark Shapiro
This network shows the impact of papers produced by Mark Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shapiro. The network helps show where Mark Shapiro may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Shapiro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2020 | 3 | |
| 3 | 2018 | 44 | |
| 4 | 2015 | 55 | |
| 5 | 2014 | 1 | |
| 6 | 2012 | 41 | |
| 7 | 2012 | 25 | |
| 8 | 2011 | 83 | |
| 9 | 2011 | 5 | |
| 10 | 2010 | 255 | |
| 11 | 2010 | 152 | |
| 12 | 2009 | 16 | |
| 13 | 2008 | 30 | |
| 14 | 2008 | 25 | |
| 15 | 2006 | 20 | |
| 16 | 1995 | 8 | |
| 17 | 1994 | 6 | |
| 18 | Malignant disease in the Transvaal. II. Tumours of the musculo-skeletal system. III. Cancer of the respiratory tract; first statistical report of the radiation therapy department of the Johannesburg group of hospitals. | 1955 | 5 |
| 19 | 1955 | 16 | |
| 20 | Malignant disease in the Transvaal. I. Cancer of the skin; first statistical report from the Radiation Therapy Department of the Johannesburg group of hospitals. | 1952 | 11 |
About Mark Shapiro
Mark Shapiro is a scholar working on Microbiology, Hematology, Genetics, Oncology and Pulmonary and Respiratory Medicine, having authored 49 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (16 papers), Chronic Lymphocytic Leukemia Research (15 papers), Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (7 papers), Eosinophilic Disorders and Syndromes (6 papers), Acute Lymphoblastic Leukemia research (6 papers), Pancreatic and Hepatic Oncology Research (4 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Hematology (351 citations), Genetics (317 citations), Microbiology (21 citations), Oncology (471 citations) and Pulmonary and Respiratory Medicine (537 citations). Mark Shapiro has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Juan P. Wisnivesky, Cynthia Chin, Todd S. Weiser, Steven Swanson, Jörge E. Cortes, Cameron D. Wright, Robert J. Korst, Shubin Sheng, Carlo Gambacorti‐Passerini and Hagop M. Kantarjian. Their work appears in journals such as Blood, Journal of Clinical Oncology, The Annals of Thoracic Surgery, Current Medical Research and Opinion and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.